Related Experiment Video
Updated: Sep 29, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation
Mark E Mazin1,2, Andrei A Yarushkin2, Yuliya A Pustylnyak1
1Novosibirsk State University, Pirogova Street, 1, Novosibirsk, Russia, 630090.
Background:
The constitutive androstane receptor (CAR, NR1I3)-mediated mechanisms regulating hepatocyte proliferation and growth of the liver did not yet experience complete elucidation. We investigated whether STAT3 could be activated in vivo by NR1I3 signaling in mouse liver.
Methods And Results:
Using Western blot analysis, immunofluorescence assays and real-time PCR we established the state of STAT3 activation when it comes to the mouse liver subsequent to treatment ofNR1I3 agonist,1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP). STAT3 nuclear relocation and hepatocyte growth were both induced by NR1I3-mediated phosphorylation of STAT3. Moreover, the NR1I3-STAT3 signaling pathway's proliferation impact was facilitated, partly, by cMyc and Cyclin D1 upregulation.
Conclusions:
This work's evidence demonstrates that NR1I3-pushed STAT3 activation contributes to TCPOBOP-induced liver growth and hepatocyte proliferation, at least in part, through its molecular targets cMyc and CyclinD1.
Insights
The constitutive androstane receptor (CAR) activates STAT3 signaling, promoting liver growth and hepatocyte proliferation. This pathway involves key targets like cMyc and Cyclin D1.
Area of Science:
- Hepatology
- Molecular Biology
- Endocrinology
Background:
- The precise mechanisms of constitutive androstane receptor (CAR, NR1I3) in regulating liver growth and hepatocyte proliferation remain incompletely understood.
- This study investigated the potential activation of STAT3 by CAR signaling within the mouse liver.
Purpose of the Study:
- To elucidate the role of STAT3 activation in CAR-mediated liver growth.
- To determine if CAR signaling in vivo can activate STAT3 in hepatocytes.
Main Methods:
- Western blot analysis
- Immunofluorescence assays
- Real-time PCR in mouse liver models
- Treatment with CAR agonist TCPOBOP
Main Results:
- CAR activation by TCPOBOP induced STAT3 phosphorylation and nuclear translocation in mouse liver.
- CAR-mediated STAT3 activation promoted hepatocyte proliferation and liver growth.
- Upregulation of cMyc and Cyclin D1 was observed, partially mediating the proliferative effects of the CAR-STAT3 pathway.
Conclusions:
- CAR-activated STAT3 signaling contributes to TCPOBOP-induced liver growth and hepatocyte proliferation.
- The molecular targets cMyc and Cyclin D1 are implicated in the CAR-STAT3 pathway's proliferative effects.
More Related Videos
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Abnormal Proliferation